Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Leuprorelin Acetate Market Report 2016

  • QYR827045
  • 103 Pages
  • December 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Leuprorelin Acetate

Revenue, means the sales value of Leuprorelin Acetate

This report studies sales (consumption) of Leuprorelin Acetate in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer, Inc. (US)

AEterna Zentaris, Inc. (Canada)

AstraZeneca Plc. (UK)

Bayer HealthCare Pharmaceuticals, Inc. (USA)

Eli Lilly and Company (USA)

Meditrina Pharmaceuticals, Inc. (US)

Neurocrine Biosciences, Inc. (US)

Abbott Laboratories (USA)

Repros Therapeutics, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Leuprorelin Acetate in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Leuprorelin Acetate in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Europe Leuprorelin Acetate Market Report 2016

1 Leuprorelin Acetate Overview

1.1 Product Overview and Scope of Leuprorelin Acetate

1.2 Classification of Leuprorelin Acetate

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Leuprorelin Acetate

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Leuprorelin Acetate Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Leuprorelin Acetate (2011-2021)

1.5.1 Europe Leuprorelin Acetate Sales and Growth Rate (2011-2021)

1.5.2 Europe Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

2 Europe Leuprorelin Acetate by Manufacturers, Type and Application

2.1 Europe Leuprorelin Acetate Market Competition by Manufacturers

2.1.1 Europe Leuprorelin Acetate Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Leuprorelin Acetate Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Leuprorelin Acetate (Volume and Value) by Type

2.2.1 Europe Leuprorelin Acetate Sales and Market Share by Type (2011-2016)

2.2.2 Europe Leuprorelin Acetate Revenue and Market Share by Type (2011-2016)

2.3 Europe Leuprorelin Acetate (Volume and Value) by Countries

2.3.1 Europe Leuprorelin Acetate Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Leuprorelin Acetate Revenue and Market Share by Countries (2011-2016)

2.4 Europe Leuprorelin Acetate (Volume) by Application

3 Germany Leuprorelin Acetate (Volume, Value and Sales Price)

3.1 Germany Leuprorelin Acetate Sales and Value (2011-2016)

3.1.1 Germany Leuprorelin Acetate Sales and Growth Rate (2011-2016)

3.1.2 Germany Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

3.1.3 Germany Leuprorelin Acetate Sales Price Trend (2011-2016)

3.2 Germany Leuprorelin Acetate Sales and Market Share by Manufacturers

3.3 Germany Leuprorelin Acetate Sales and Market Share by Type

3.4 Germany Leuprorelin Acetate Sales and Market Share by Application

4 France Leuprorelin Acetate (Volume, Value and Sales Price)

4.1 France Leuprorelin Acetate Sales and Value (2011-2016)

4.1.1 France Leuprorelin Acetate Sales and Growth Rate (2011-2016)

4.1.2 France Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

4.1.4 France Leuprorelin Acetate Sales Price Trend (2011-2016)

4.2 France Leuprorelin Acetate Sales and Market Share by Manufacturers

4.3 France Leuprorelin Acetate Sales and Market Share by Type

4.4 France Leuprorelin Acetate Sales and Market Share by Application

5 UK Leuprorelin Acetate (Volume, Value and Sales Price)

5.1 UK Leuprorelin Acetate Sales and Value (2011-2016)

5.1.1 UK Leuprorelin Acetate Sales and Growth Rate (2011-2016)

5.1.2 UK Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

5.1.5 UK Leuprorelin Acetate Sales Price Trend (2011-2016)

5.2 UK Leuprorelin Acetate Sales and Market Share by Manufacturers

5.3 UK Leuprorelin Acetate Sales and Market Share by Type

5.4 UK Leuprorelin Acetate Sales and Market Share by Application

6 Russia Leuprorelin Acetate (Volume, Value and Sales Price)

6.1 Russia Leuprorelin Acetate Sales and Value (2011-2016)

6.1.1 Russia Leuprorelin Acetate Sales and Growth Rate (2011-2016)

6.1.2 Russia Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

6.1.6 Russia Leuprorelin Acetate Sales Price Trend (2011-2016)

6.2 Russia Leuprorelin Acetate Sales and Market Share by Manufacturers

6.3 Russia Leuprorelin Acetate Sales and Market Share by Type

6.4 Russia Leuprorelin Acetate Sales and Market Share by Application

7 Italy Leuprorelin Acetate (Volume, Value and Sales Price)

7.1 Italy Leuprorelin Acetate Sales and Value (2011-2016)

7.1.1 Italy Leuprorelin Acetate Sales and Growth Rate (2011-2016)

7.1.2 Italy Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

7.1.7 Italy Leuprorelin Acetate Sales Price Trend (2011-2016)

7.2 Italy Leuprorelin Acetate Sales and Market Share by Manufacturers

7.3 Italy Leuprorelin Acetate Sales and Market Share by Type

7.4 Italy Leuprorelin Acetate Sales and Market Share by Application

8 Spain Leuprorelin Acetate (Volume, Value and Sales Price)

8.1 Spain Leuprorelin Acetate Sales and Value (2011-2016)

8.1.1 Spain Leuprorelin Acetate Sales and Growth Rate (2011-2016)

8.1.2 Spain Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

8.1.8 Spain Leuprorelin Acetate Sales Price Trend (2011-2016)

8.2 Spain Leuprorelin Acetate Sales and Market Share by Manufacturers

8.3 Spain Leuprorelin Acetate Sales and Market Share by Type

8.4 Spain Leuprorelin Acetate Sales and Market Share by Application

9 Benelux Leuprorelin Acetate (Volume, Value and Sales Price)

9.1 Benelux Leuprorelin Acetate Sales and Value (2011-2016)

9.1.1 Benelux Leuprorelin Acetate Sales and Growth Rate (2011-2016)

9.1.2 Benelux Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Leuprorelin Acetate Sales Price Trend (2011-2016)

9.2 Benelux Leuprorelin Acetate Sales and Market Share by Manufacturers

9.3 Benelux Leuprorelin Acetate Sales and Market Share by Type

9.4 Benelux Leuprorelin Acetate Sales and Market Share by Application

10 Europe Leuprorelin Acetate Manufacturers Analysis

10.1 Pfizer, Inc. (US)

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Leuprorelin Acetate Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Pfizer, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 AEterna Zentaris, Inc. (Canada)

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Leuprorelin Acetate Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 AstraZeneca Plc. (UK)

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Leuprorelin Acetate Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 AstraZeneca Plc. (UK) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Bayer HealthCare Pharmaceuticals, Inc. (USA)

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Leuprorelin Acetate Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Eli Lilly and Company (USA)

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Leuprorelin Acetate Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Eli Lilly and Company (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Meditrina Pharmaceuticals, Inc. (US)

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Leuprorelin Acetate Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Neurocrine Biosciences, Inc. (US)

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Leuprorelin Acetate Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Abbott Laboratories (USA)

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Leuprorelin Acetate Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Abbott Laboratories (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Repros Therapeutics, Inc. (US)

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Leuprorelin Acetate Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

11 Leuprorelin Acetate Manufacturing Cost Analysis

11.1 Leuprorelin Acetate Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Leuprorelin Acetate

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Leuprorelin Acetate Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Leuprorelin Acetate Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Leuprorelin Acetate Market Forecast (2016-2021)

14.1 Germany Leuprorelin Acetate Sales Forecast (2016-2021)

14.2 France Leuprorelin Acetate Sales Forecast (2016-2021)

14.3 UK Leuprorelin Acetate Sales Forecast (2016-2021)

14.4 Russia Leuprorelin Acetate Sales Forecast (2016-2021)

14.5 Italy Leuprorelin Acetate Sales Forecast (2016-2021)

14.6 Spain Leuprorelin Acetate Sales Forecast (2016-2021)

14.7 Benelux Leuprorelin Acetate Sales Forecast (2016-2021)

14.8 Europe Leuprorelin Acetate Sales Forecast by Type (2016-2021)

14.9 Europe Leuprorelin Acetate Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Leuprorelin Acetate

Table Classification of Leuprorelin Acetate

Figure Europe Sales Market Share of Leuprorelin Acetate by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Leuprorelin Acetate

Figure Europe Sales Market Share of Leuprorelin Acetate by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure France Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure UK Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure Russia Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure Italy Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure Spain Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure Benelux Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Figure Europe Leuprorelin Acetate Sales and Growth Rate (2011-2021)

Figure Europe Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

Table Europe Leuprorelin Acetate Sales of Key Manufacturers (2015 and 2016)

Table Europe Leuprorelin Acetate Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Leuprorelin Acetate Sales Share by Manufacturers

Figure 2016 Leuprorelin Acetate Sales Share by Manufacturers

Table Europe Leuprorelin Acetate Revenue by Manufacturers (2015 and 2016)

Table Europe Leuprorelin Acetate Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Leuprorelin Acetate Revenue Share by Manufacturers

Table 2016 Europe Leuprorelin Acetate Revenue Share by Manufacturers

Table Europe Leuprorelin Acetate Sales and Market Share by Type (2011-2016)

Table Europe Leuprorelin Acetate Sales Share by Type (2011-2016)

Figure Sales Market Share of Leuprorelin Acetate by Type (2011-2016)

Figure Europe Leuprorelin Acetate Sales Growth Rate by Type (2011-2016)

Table Europe Leuprorelin Acetate Revenue and Market Share by Type (2011-2016)

Table Europe Leuprorelin Acetate Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Leuprorelin Acetate by Type (2011-2016)

Figure Europe Leuprorelin Acetate Revenue Growth Rate by Type (2011-2016)

Table Europe Leuprorelin Acetate Sales and Market Share by Countries (2011-2016)

Table Europe Leuprorelin Acetate Sales Share by Countries (2011-2016)

Figure Sales Market Share of Leuprorelin Acetate by Countries (2011-2016)

Table Europe Leuprorelin Acetate Revenue and Market Share by Countries (2011-2016)

Table Europe Leuprorelin Acetate Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Leuprorelin Acetate by Countries (2011-2016)

Table Europe Leuprorelin Acetate Sales and Market Share by Application (2011-2016)

Table Europe Leuprorelin Acetate Sales Share by Application (2011-2016)

Figure Sales Market Share of Leuprorelin Acetate by Application (2011-2016)

Figure Germany Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure Germany Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure Germany Leuprorelin Acetate Sales Price Trend (2011-2016)

Table Germany Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table Germany Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table Germany Leuprorelin Acetate Sales by Type (2015 and 2016)

Table Germany Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table Germany Leuprorelin Acetate Sales by Application (2015 and 2016)

Table Germany Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure France Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure France Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure France Leuprorelin Acetate Sales Price Trend (2011-2016)

Table France Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table France Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table France Leuprorelin Acetate Sales by Type (2015 and 2016)

Table France Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table France Leuprorelin Acetate Sales by Application (2015 and 2016)

Table France Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure UK Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure UK Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure UK Leuprorelin Acetate Sales Price Trend (2011-2016)

Table UK Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table UK Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table UK Leuprorelin Acetate Sales by Type (2015 and 2016)

Table UK Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table UK Leuprorelin Acetate Sales by Application (2015 and 2016)

Table UK Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure Russia Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure Russia Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure Russia Leuprorelin Acetate Sales Price Trend (2011-2016)

Table Russia Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table Russia Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table Russia Leuprorelin Acetate Sales by Type (2015 and 2016)

Table Russia Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table Russia Leuprorelin Acetate Sales by Application (2015 and 2016)

Table Russia Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure Italy Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure Italy Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure Italy Leuprorelin Acetate Sales Price Trend (2011-2016)

Table Italy Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table Italy Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table Italy Leuprorelin Acetate Sales by Type (2015 and 2016)

Table Italy Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table Italy Leuprorelin Acetate Sales by Application (2015 and 2016)

Table Italy Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure Spain Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure Spain Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure Spain Leuprorelin Acetate Sales Price Trend (2011-2016)

Table Spain Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table Spain Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table Spain Leuprorelin Acetate Sales by Type (2015 and 2016)

Table Spain Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table Spain Leuprorelin Acetate Sales by Application (2015 and 2016)

Table Spain Leuprorelin Acetate Market Share by Application (2015 and 2016)

Figure Benelux Leuprorelin Acetate Sales and Growth Rate (2011-2016)

Figure Benelux Leuprorelin Acetate Revenue and Growth Rate (2011-2016)

Figure Benelux Leuprorelin Acetate Sales Price Trend (2011-2016)

Table Benelux Leuprorelin Acetate Sales by Manufacturers (2015 and 2016)

Table Benelux Leuprorelin Acetate Market Share by Manufacturers (2015 and 2016)

Table Benelux Leuprorelin Acetate Sales by Type (2015 and 2016)

Table Benelux Leuprorelin Acetate Market Share by Type (2015 and 2016)

Table Benelux Leuprorelin Acetate Sales by Application (2015 and 2016)

Table Benelux Leuprorelin Acetate Market Share by Application (2015 and 2016)

Table Leuprorelin Acetate Basic Information List

Table Pfizer, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)

Table AEterna Zentaris, Inc. (Canada) Basic Information List

Table AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales Market Share (2011-2016)

Table AstraZeneca Plc. (UK) Basic Information List

Table AstraZeneca Plc. (UK) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Plc. (UK) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Eli Lilly and Company (USA) Basic Information List

Table Eli Lilly and Company (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly and Company (USA) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List

Table Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Neurocrine Biosciences, Inc. (US) Basic Information List

Table Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Laboratories (USA) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Repros Therapeutics, Inc. (US) Basic Information List

Table Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Leuprorelin Acetate

Figure Manufacturing Process Analysis of Leuprorelin Acetate

Figure Leuprorelin Acetate Industrial Chain Analysis

Table Raw Materials Sources of Leuprorelin Acetate Major Manufacturers in 2015

Table Major Buyers of Leuprorelin Acetate

Table Distributors/Traders List

Figure Germany Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure Germany Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure France Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure France Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure UK Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure UK Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure Russia Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure Italy Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure Spain Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Leuprorelin Acetate Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)

Table Europe Leuprorelin Acetate Sales Forecast by Type (2016-2021)

Table Europe Leuprorelin Acetate Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370